The development of innovative medicines, an important part of personalised or precision medicine, will be carried out through the formation of a platform integrated by health research foundations, and will be led by the La Fe Health Research Institute (IISLaFe). The development of new medicines in the medium term can lead to an increase in efficiency in terms of cost and time, and effectiveness in terms of clinical impact. This operation will strengthen research infrastructures in this area of research.